• News

IO Biotech CEO a panelist at Cancer Progress Conference

CEO of IO Biotech, Mai-Britt Zocca, will be sitting at the Immuno-Oncology I: Attacking Cancer Antigens – Exploiting Off-the-Shelf And Personalized Vaccines and Triggering of Immunogenic Cell Death panel for the 27th Annual Cancer Progress Conference, in New York City on March 8-9, 2016.

Continue Reading